Literature DB >> 7261539

Arterial plasma histamine after exercise in normal individuals an in patients with exercise-induced asthma.

J P Hartley, T J Charles, R D Monie, A Seaton, W H Taylor, A Westwood, J D Williams.   

Abstract

1. Arterial plasma histamine concentrations, forced expiratory volume in 1.0 s (FEV1.0) and peak expiratory flow rate were determined in nine patients with exercise-induced asthma and in five control subjects before and after 8 min of cycle-ergometer exercise. 2. In the controls neither FEV1.0 nor peak expiratory flow rate fell by more than 5% in any individual during the 30 min postexercise period. The asthmatic patients all experienced a fall in FEV1.0 or peak expiratory flow rate, or both, of 15% or more in the period 5-20 min after completion of the exercise. 3. There was no difference between the control subjects and the asthmatic patients in the plasma histamine response to exercise. In both groups there was an insignificant rise of about 40% during exercise, although the initial levels were higher in the asthmatic patients. 4. The mean plasma histamine peak of the asthmatic patients preceded the mean maximal fall of FEV1.0 and peak expiratory flow rate by approximately 15 min. However, no positive correlation was found between rise in, or peak, plasma histamine levels and decrease in lung function. 5. Three non-atopic asthmatic patients had a significantly higher mean plasma histamine concentration during exercise than had the atopic subjects. 6. A strong positive correlation in asthmatic patients, and asthmatic and control subjects together was found between age and mean postexercise plasma histamine concentrations. 7. The results do not support a direct role for histamine in the production of exercise-induced asthma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261539     DOI: 10.1042/cs0610151

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

Review 1.  Exercise-induced arterial hypoxaemia in athletes: a review.

Authors:  C Prefaut; F Durand; P Mucci; C Caillaud
Journal:  Sports Med       Date:  2000-07       Impact factor: 11.136

2.  H1 receptor-mediated vasodilatation contributes to postexercise hypotension.

Authors:  Jennifer M Lockwood; Brad W Wilkins; John R Halliwill
Journal:  J Physiol       Date:  2004-12-23       Impact factor: 5.182

3.  Plasma histamine and clinical tolerance to infused histamine in normal, atopic and urticarial subjects.

Authors:  I Pollock; R D Murdoch; M H Lessof
Journal:  Agents Actions       Date:  1991-03

4.  Biorhythmic changes of plasma histamine levels in healthy volunteers.

Authors:  D Rehn; H J Reimann; M von der Ohe; U Schmidt; A Schmel; G Hennings
Journal:  Agents Actions       Date:  1987-10

Review 5.  Pathogenesis of occupational lung disease.

Authors:  B F Paterson; R Patterson; L C Grammer
Journal:  Clin Rev Allergy       Date:  1986-08

Review 6.  Heterogeneity of mechanisms in exercise induced asthma.

Authors:  T H Lee; S D Anderson
Journal:  Thorax       Date:  1985-07       Impact factor: 9.139

7.  Plasma histamine in asthmatic and control subjects following exercise: influence of circulating basophils and different assay techniques.

Authors:  D J Morgan; I Moodley; M J Phillips; R J Davies
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

Review 8.  Exercise-induced asthma.

Authors:  P A Eggleston
Journal:  Clin Rev Allergy       Date:  1983-03

9.  Urinary excretion of 9α,11β-prostaglandin F2 and leukotriene E4 in patients with exercise-induced bronchoconstriction.

Authors:  Tae-Rim Shin; Joo-Hee Kim; Cheol-Hong Kim; In-Gyu Hyun; Jeong-Hee Choi
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

10.  Mast cell degranulation and de novo histamine formation contribute to sustained postexercise vasodilation in humans.

Authors:  Steven A Romero; Jennifer L McCord; Matthew R Ely; Dylan C Sieck; Tahisha M Buck; Meredith J Luttrell; David A MacLean; John R Halliwill
Journal:  J Appl Physiol (1985)       Date:  2016-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.